Logo image of IRES.I

IRISH RESIDENTIAL PROPERTIES (IRES.I) Stock Fundamental Analysis

DUB:IRES - IE00BJ34P519 - REIT

0.989 EUR
+0 (+0.3%)
Last: 9/5/2025, 5:20:18 PM
Fundamental Rating

4

Overall IRES gets a fundamental rating of 4 out of 10. We evaluated IRES against 5 industry peers in the Residential REITs industry. There are concerns on the financial health of IRES while its profitability can be described as average. IRES has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year IRES was profitable.
IRES had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: IRES reported negative net income in multiple years.
Each year in the past 5 years IRES had a positive operating cash flow.
IRES.I Yearly Net Income VS EBIT VS OCF VS FCFIRES.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.39%, IRES is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
The Return On Equity of IRES (4.50%) is better than 80.00% of its industry peers.
IRES has a Return On Invested Capital of 3.78%. This is in the better half of the industry: IRES outperforms 80.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IRES is in line with the industry average of 3.10%.
The last Return On Invested Capital (3.78%) for IRES is above the 3 year average (3.55%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.39%
ROE 4.5%
ROIC 3.78%
ROA(3y)-3.41%
ROA(5y)-0.34%
ROE(3y)-6.34%
ROE(5y)-0.89%
ROIC(3y)3.55%
ROIC(5y)3.34%
IRES.I Yearly ROA, ROE, ROICIRES.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

The Profit Margin of IRES (35.22%) is comparable to the rest of the industry.
Looking at the Operating Margin, with a value of 62.47%, IRES is in line with its industry, outperforming 60.00% of the companies in the same industry.
In the last couple of years the Operating Margin of IRES has declined.
IRES has a Gross Margin (78.86%) which is in line with its industry peers.
IRES's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 62.47%
PM (TTM) 35.22%
GM 78.86%
OM growth 3Y-1.31%
OM growth 5Y-1.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.79%
GM growth 5Y-1.09%
IRES.I Yearly Profit, Operating, Gross MarginsIRES.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IRES is destroying value.
Compared to 1 year ago, IRES has about the same amount of shares outstanding.
Compared to 5 years ago, IRES has more shares outstanding
IRES has a worse debt/assets ratio than last year.
IRES.I Yearly Shares OutstandingIRES.I Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
IRES.I Yearly Total Debt VS Total AssetsIRES.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 0.86, we must say that IRES is in the distress zone and has some risk of bankruptcy.
IRES has a Altman-Z score of 0.86. This is in the better half of the industry: IRES outperforms 80.00% of its industry peers.
The Debt to FCF ratio of IRES is 10.47, which is on the high side as it means it would take IRES, 10.47 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.47, IRES is in line with its industry, outperforming 60.00% of the companies in the same industry.
IRES has a Debt/Equity ratio of 0.84. This is a neutral value indicating IRES is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.84, IRES is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 10.47
Altman-Z 0.86
ROIC/WACC0.71
WACC5.35%
IRES.I Yearly LT Debt VS Equity VS FCFIRES.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

IRES has a Current Ratio of 0.85. This is a bad value and indicates that IRES is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.85, IRES is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
A Quick Ratio of 0.85 indicates that IRES may have some problems paying its short term obligations.
IRES's Quick ratio of 0.85 is amongst the best of the industry. IRES outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85
IRES.I Yearly Current Assets VS Current LiabilitesIRES.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

IRES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 132.61%, which is quite impressive.
Looking at the last year, IRES shows a decrease in Revenue. The Revenue has decreased by -1.50% in the last year.
The Revenue has been growing slightly by 6.55% on average over the past years.
EPS 1Y (TTM)132.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%180.99%
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y2.26%
Revenue growth 5Y6.55%
Sales Q2Q%-0.42%

3.2 Future

Based on estimates for the next years, IRES will show a very strong growth in Earnings Per Share. The EPS will grow by 25.39% on average per year.
IRES is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.39% yearly.
EPS Next Y7.94%
EPS Next 2Y26.74%
EPS Next 3Y25.39%
EPS Next 5YN/A
Revenue Next Year-13.39%
Revenue Next 2Y-5.74%
Revenue Next 3Y-3.39%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IRES.I Yearly Revenue VS EstimatesIRES.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
IRES.I Yearly EPS VS EstimatesIRES.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.02 0.04 0.06 0.08 0.1

4

4. Valuation

4.1 Price/Earnings Ratio

IRES is valuated correctly with a Price/Earnings ratio of 16.48.
The rest of the industry has a similar Price/Earnings ratio as IRES.
IRES's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.03.
With a Price/Forward Earnings ratio of 11.50, the valuation of IRES can be described as very reasonable.
IRES's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. IRES is cheaper than 80.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IRES to the average of the S&P500 Index (22.63), we can say IRES is valued slightly cheaper.
Industry RankSector Rank
PE 16.48
Fwd PE 11.5
IRES.I Price Earnings VS Forward Price EarningsIRES.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as IRES.
IRES's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 9.74
EV/EBITDA 19.83
IRES.I Per share dataIRES.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
IRES's earnings are expected to grow with 25.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.08
PEG (5Y)N/A
EPS Next 2Y26.74%
EPS Next 3Y25.39%

4

5. Dividend

5.1 Amount

IRES has a Yearly Dividend Yield of 5.36%, which is a nice return.
IRES's Dividend Yield is comparable with the industry average which is at 5.57.
IRES's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 5.36%

5.2 History

The dividend of IRES decreases each year by -7.31%.
Dividend Growth(5Y)-7.31%
Div Incr Years0
Div Non Decr Years0
IRES.I Yearly Dividends per shareIRES.I Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

IRES pays out 72.09% of its income as dividend. This is not a sustainable payout ratio.
DP72.09%
EPS Next 2Y26.74%
EPS Next 3Y25.39%
IRES.I Yearly Income VS Free CF VS DividendIRES.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
IRES.I Dividend Payout.IRES.I Dividend Payout, showing the Payout Ratio.IRES.I Dividend Payout.PayoutRetained Earnings

IRISH RESIDENTIAL PROPERTIES

DUB:IRES (9/5/2025, 5:20:18 PM)

0.989

+0 (+0.3%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)08-08 2025-08-08
Earnings (Next)02-18 2026-02-18
Inst Owners74.23%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap518.67M
Analysts82.22
Price Target1.45 (46.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.36%
Yearly Dividend0.04
Dividend Growth(5Y)-7.31%
DP72.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.4%
PT rev (3m)49.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.04%
EPS NY rev (3m)3.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.35%
Valuation
Industry RankSector Rank
PE 16.48
Fwd PE 11.5
P/S 6.1
P/FCF 9.74
P/OCF 9.65
P/B 0.78
P/tB 0.78
EV/EBITDA 19.83
EPS(TTM)0.06
EY6.07%
EPS(NY)0.09
Fwd EY8.7%
FCF(TTM)0.1
FCFY10.27%
OCF(TTM)0.1
OCFY10.37%
SpS0.16
BVpS1.27
TBVpS1.27
PEG (NY)2.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.39%
ROE 4.5%
ROCE 4.31%
ROIC 3.78%
ROICexc 3.8%
ROICexgc 3.8%
OM 62.47%
PM (TTM) 35.22%
GM 78.86%
FCFM 62.61%
ROA(3y)-3.41%
ROA(5y)-0.34%
ROE(3y)-6.34%
ROE(5y)-0.89%
ROIC(3y)3.55%
ROIC(5y)3.34%
ROICexc(3y)3.57%
ROICexc(5y)3.36%
ROICexgc(3y)3.57%
ROICexgc(5y)3.36%
ROCE(3y)4.06%
ROCE(5y)3.82%
ROICexcg growth 3Y7.78%
ROICexcg growth 5Y6.87%
ROICexc growth 3Y7.78%
ROICexc growth 5Y6.87%
OM growth 3Y-1.31%
OM growth 5Y-1.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.79%
GM growth 5Y-1.09%
F-Score7
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 10.47
Debt/EBITDA 10.35
Cap/Depr 73.77%
Cap/Sales 0.58%
Interest Coverage 2.41
Cash Conversion 99.89%
Profit Quality 177.74%
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z 0.86
F-Score7
WACC5.35%
ROIC/WACC0.71
Cap/Depr(3y)6.38%
Cap/Depr(5y)10.26%
Cap/Sales(3y)0.04%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)132.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%180.99%
EPS Next Y7.94%
EPS Next 2Y26.74%
EPS Next 3Y25.39%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y2.26%
Revenue growth 5Y6.55%
Sales Q2Q%-0.42%
Revenue Next Year-13.39%
Revenue Next 2Y-5.74%
Revenue Next 3Y-3.39%
Revenue Next 5YN/A
EBIT growth 1Y-0.41%
EBIT growth 3Y0.92%
EBIT growth 5Y4.63%
EBIT Next Year-22.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.04%
FCF growth 3Y-1.51%
FCF growth 5Y2.93%
OCF growth 1Y1.87%
OCF growth 3Y-1.49%
OCF growth 5Y2.94%